EFSD and Sanofi European Pilot Research Grants for Innovative Measurement of Diabetes Outcomes
Deadline Date: 15 March 2018
The European Foundation for the Study of Diabetes (EFSD) was created by the European Association for the Study of Diabetes (EASD) to provide funding initiatives in all areas of diabetes research. The aims of EFSD are to encourage and support research in the field of diabetes, to rapidly diffuse acquired knowledge and to facilitate its application.
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi Diabetes and Cardiovascular is dedicated to delivering innovative, value-based medicines and integrated solutions. Sanofi is committed to a collaborative approach that involves strategic alliances with professional and patient associations, research institutions and leaders in healthcare and other industries, with the goal of advancing scientific knowledge, driving the convergence of science and technology, helping to improve outcomes and inspiring an evolution in care.
Programme and Research Focus
EFSD and Sanofi have established a new programme called the EFSD/Sanofi European Pilot Research Grants for Innovative Measurement of Diabetes Outcomes to encourage new projects aimed at advancing current knowledge in this field.
To achieve the goals and objectives of this Programme, EFSD and Sanofi invite applications by issuing this "Request for Applications" (RFA), which indicates joint funding as well as areas of research emphasis.
These EFSD/Sanofi European Pilot Research Grants are intended to help develop innovative means to document and validate novel parameters indicative of long-term benefits for patients with diabetes.
In spite of the growing evidence of the complexity and multifaceted aspects of diabetes, the management of the disease still remains anchored on the lowering of HbA1c. Long term HbA1c lowering has been proven effective at reducing the risk for late complications in randomised clinical trials. Despite the large body of evidence on the value of HbA1c lowering in these studies, achieving target HbA1c is often unmet in the clinical practice of medicine. The life-long duration of the disease, the economic, social, psychological, and physiological burden and limited appreciation of individual needs are likely important interfering factors that contribute to the complexity of the task. Because of such complexity, HbA1c might not be the only “metric” of relevance to assess the possibility for a treatment strategy to provide long term benefit and improved quality of life.
We are now seeking pilot proposals for innovative definition and measurement of outcomes in diabetes. Proposals may include, but need not be limited to, the validation of behavioural, biological, and disease management metrics to complement HbA1c in defining the quality of the long term management of diabetes.
Mechanism of Support and Review
Research will be supported through the award of pilot grants, each of up to Euro 100,000 The duration of each award may be one year or longer, depending upon the needs of the project and as justified in the application. EFSD may, on advisement from the Review Committee, recommend an award in a different amount from that requested, but which is considered more appropriate for the proposed studies.
Applicants who have a funding requirement larger than that specified above are also invited to apply to this Programme: in this case, the relevant financial requirements should be well justified in the budget section of the application form for special consideration by the review committee.
Studies forming part of a larger project will be considered for funding but this will need to be well justified in the application (see Review Considerations).
Applications for an EFSD/Sanofi grant are invited from single non-profit institutions or groups of such institutions from Europe and associated countries. The principal investigator and any co-investigators must be employed full-time at a non-profit institution and the study must be performed at their place of work.
Applications will be subject to scientific review by a specialised and independent ad hoc committee. It is anticipated that applications will be received, reviewed and approved for funding by June/July 2018.
Prior to any final decision on funding, and in order to offer applicants the opportunity to benefit from the review process, EFSD reserves the right to request revision of applications in accordance with the recommendations of the Review Committee.
Research Grant Applications
Applications for research grants may be subjected to pre-review (or triage) procedures. In this event, any application rejected at pre-review will not be subject to a complete scientific review and no feedback report will be provided to the applicant.
The deadline for receipt of research grant applications for funding this year is 15 March 2018.
All budgets are to be prepared in Euro. For countries in which the Euro is not the common currency, the exchange rate (between the Euro and the local currency in the country where the work is to be performed) used for calculating the Euro budget must be mentioned under "Budget Justification".
All applications must be prepared on the official application form and completed in strict accordance with the detailed instructions to be found on these forms. Applications which do not comply with the instructions given in the application form will not be considered for review.
Please send your application as one complete PDF email attachment to the following address before 12:00 midday (CET) on the deadline date: Foundation@easd.org
Completed applications will be evaluated in accordance with the criteria stated below for scientific/technical merit by an appropriate and independent scientific committee.
Review criteria are as follows:
Reporting Requirements and Approval of Funding
All investigators funded by this Programme are required to submit a scientific report at the end of the project period. For those projects where funding is distributed over a period of more than one year, interim progress reports will also be required. Such reports will be subject to assessment prior to the release of any further funds.
Investigators must provide EFSD with copies of papers accepted for publication, and must acknowledge the support of the Programme in all written material by use of the phrase: "supported by an EFSD/Sanofi research grant".
Applications for a grant renewal will be accepted on a competitive basis, with the same review process as described in this Announcement. Such applications will therefore be considered in the same fashion as all other new applications received for review and without any special priority.
|Application Deadline||15 March 2018|
|Anticipated Award Date||June/July 2018|